141
Por Eugenín, Eliseo A., Eckardt, Dominik, Theis, Martin, Willecke, Klaus, Bennett, Michael V. L., Sáez, Juan C.
Publicado em 2001
“..., a gap junction protein subunit. At brain stab wounds, microglia progressively accumulated over...”Publicado em 2001
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
142
Por Hu, Jinwei, Ljubimova, Julia Y., Inoue, Satoshi, Konda, Bindu, Patil, Rameshwar, Ding, Hui, Espinoza, Andres, Wawrowsky, Kolja A., Patil, Chirag, Ljubimov, Alexander V., Black, Keith L.
Publicado em 2010
“... are adequately delivered to most solid and systemic tumors. However, drug delivery into primary brain tumors...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
143
Por Muramatsu, Takashi
Publicado em 2011
“...Midkine (MK) is a heparin-binding cytokine, and promotes growth, survival, migration and other...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
144
Por Moertel, Christopher, Pluhar, G Elizabeth, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Pennell, Christopher A, Rathe, Susan K, Largaespada, David A, Olin, Michael R
Publicado no Neuro Oncol (2019)
“.... In this light, CD200AR-L may be a powerful immunotherapy platform for other solid tumors. This innovative...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
145
“...Brain metastases (BM) affect approximately a third of all cancer patients with systemic disease...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
146
Por Doger de Speville, Elodie, Robert, Charlotte, Perez-Guevara, Martin, Grigis, Antoine, Bolle, Stephanie, Pinaud, Clemence, Dufour, Christelle, Beaudré, Anne, Kieffer, Virginie, Longaud, Audrey, Grill, Jacques, Valteau-Couanet, Dominique, Deutsch, Eric, Lefkopoulos, Dimitri, Chiron, Catherine, Hertz-Pannier, Lucie, Noulhiane, Marion
Publicado no Front Oncol (2017)
“...Pediatric posterior fossa tumor (PFT) survivors who have been treated with cranial radiation...”Publicado no Front Oncol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
147
Por Mathis, Sarah E., Alberico, Anthony, Nande, Rounak, Neto, Walter, Lawrence, Logan, McCallister, Danielle R., Denvir, James, Kimmey, Gerrit A., Mogul, Mark, Oakley, Gerard, Denning, Krista L., Dougherty, Thomas, Valluri, Jagan V., Claudio, Pier Paolo
Publicado em 2014
“... sensitivity assay (ChemoID), which measures the sensitivity of CSLCs as well as the bulk of tumor cells to a...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
148
Por Howarth, Robyn A., Adamson, Amanda M., Ashford, Jason M., Merchant, Thomas E., Ogg, Robert J., Schulenberg, Stefan E., Ogg, Susan, Li, Jiang, Wu, Shengjie, Xiong, Xiaoping, Conklin, Heather M.
Publicado em 2013
“... brain tumor survivors. PROCEDURE: Children treated for a brain tumor with conformal radiation therapy (N...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
149
Por Pan, Zhenyu, Yang, Guozi, He, Hua, Zhao, Gang, Yuan, Tingting, Li, Yu, Shi, Weiyan, Gao, Pengxiang, Dong, Lihua, Li, Yunqian
Publicado no Int J Cancer (2016)
“...) for treating LM from solid tumors with adverse prognostic factors. Fifty‐nine patients with LM from various...”Publicado no Int J Cancer (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
150
Por Garren, Nancy, Acquaye, Alvina A, Vera, Elizabeth, Lisa, Boris, Siegel, Christine, Park, Deric M, Sul, Joo-Hee, Theeler, Brett J, Wu, Jing, Crandon, Sonja, Gilbert, Mark, Armstrong, Terri
Publicado no Neuro Oncol (2017)
“...BACKGROUND: Management of brain tumor patients can be complicated as anxiety may blur the lines...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
151
Por Vetlova, Elena, Golbin, Denis A, Golanov, Andrey V., Potapov, Alexander A, Banov, Sergey M, Antipina, Natalia, Kostjuchenko, Valery V, Usachev, Dmitry Y, Belyaev, Artem Y, Goryaynov, Sergey
Publicado no Cureus (2017)
“... as illustrative cases. Conclusion: The combined treatment of secondary brain tumors has proved to be the best...”Publicado no Cureus (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
152
Por Lacouture, M, Hershkovich, H, Giladi, M, Blat, R, Bomzon, Z, Kirson, E, Weinberg, U, Palti, Y
Publicado no Neuro Oncol (2018)
“...BACKGROUND: Tumor Treating Fields are low intensity, intermediate frequency, alternating electric...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
153
Por Shapovalov, Yuriy, Zettel, Martha, Spielman, Sara C, Amico-Ruvio, Stacy A, Kelly, Emily A, Sipe, Grayson O, Dickerson, Ian M, Majewska, Ania K, Brown, Edward B
Publicado no BMC Cancer (2014)
“... substances may influence the pathogenesis of brain metastatic disease. This provides a starting point...”Publicado no BMC Cancer (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
154
“...) injected subcutaneously into the tumor-bearing hindpaw produced a dose-dependent decrease in paw withdrawal...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
155
“... with no escalating doses (10 mg/kg, twice a day) did not alter CCL5 levels compared to saline-treated animals...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
156
“... the BBB: 1) Pharmaceutical methamphetamine may have a useful role in treating both CML and glioblastoma...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
157
Por Wu, Yingjen Jeffrey, Muldoon, Leslie L., Dickey, Dana Thomas, Lewin, Seth J., Varallyay, Csanad G., Neuwelt, Edward A.
Publicado em 2009
“.... Cyclophosphamide may enhance primary and metastatic tumor growth through multiple mechanisms, including immune...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Artigo
158
“...BACKGROUND: Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
159
Por WEI, HANGPING, SU, MENG, LIN, RUIFANG, LI, HUIFANG, ZOU, CHANGLIN
Publicado no Oncol Lett (2016)
“... epidermal growth factor receptor (EGFR) mutation alongside NSCLC with brain metastases also have a short...”Publicado no Oncol Lett (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
160
“... treating fields (TTFields) are a regional non-invasive, antimitotic treatment with minimal toxicity...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo